Sierra Leone

in page functions
[French]
Sierra Leone
Total population (2017) 6,732,899
Birth cohort (2017) 231,757
Surviving Infants (surviving to 1 year per year, 2017) 212,762
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 87/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 120/1000
World Bank Index, IDA (2015) 3.27
Gross Nation Income (per capita US$, 2015) 620
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 14

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Sierra Leone

Type of support

Approvals

2001-2022 (US$)
(28 Mar 2018)

Commitments

2001-2022 (US$)
(28 Mar 2018)

Disbursements

2000-2018 (US$)
(28 Mar 2018)

% Disbursed

(28 Mar 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $71,794,265 $93,176,282 $64,293,455
Cash Support (CASHSUPP) $195,000 $195,000 $170,000 87%
Cold Chain Equipment Optimisation Platform (CCEOP) $1,302,611 $1,302,611 $1,301,914 100%
Ebola EPI Recovery Plan (EEPIRP) $3,819,373 $3,819,373 $3,819,373 100%
Health system strengthening (HSS 1) $1,161,447 $1,161,447 $1,161,447 100%
Health system strengthening (HSS 2) N/A
Health system strengthening (HSS 3) $8,237,983 $12,880,000 $349,725 4%
HPV Demo (NVS) $180,664 $180,664 $181,529 100%
Immunisation services support (ISS) $2,655,440 $2,655,440 $2,655,440 100%
Injection Safety Devices (NVS) $208,500 $552,000 $274,546 132%
Injection safety support (INS) $272,660 $272,660 $272,660 100%
IPV (NVS) $224,061 $224,061 $108,361 48%
Measles (NVS) $280,500 $280,500 $295,799 105%
Penta (NVS) $17,539,937 $19,280,437 $17,446,895 99%
Pneumo (NVS) $26,859,476 $37,114,476 $27,569,795 103%
Rotavirus (NVS) $4,986,661 $8,459,661 $4,671,865 94%
Vaccine Introduction Grant (VIG) $782,500 $782,500 $782,500 100%
Yellow Fever (NVS) $3,087,452 $4,015,452 $3,231,606 105%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Sierra Leone DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 84%
M:F sex ratio at birth (2017) 1.02
Household survey: DTP3 coverage for male (2012) 77.80%
Household survey: DTP3 coverage for female (2012) 77.90%
Household survey: Last DTP3 survey (2012) 78%
% districts achieving > 80% DTP3 coverage (2016) 86%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 83%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$10,513,059 $53,780,396

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Sierra Leone

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

24 October 2017

Aspen statement - Gavi CEO Seth Berkley and Peggy Clark, ED, Aspen Global Innovators Group

Gavi and the Aspen Institute to strengthen health management capacity in developing countries

Malawi will be the first country to benefit from the new partnership .

05 September 2017

Gavi item

Sierra Leone to begin cholera vaccination drive in disaster-affected areas

More than 1 million doses of Gavi-funded cholera vaccines heading to Sierra Leone after severe flooding and landslides.

close icon

modal window here